These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31023759)

  • 1. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.
    Chang AB; Fong SM; Yeo TW; Ware RS; McCallum GB; Nathan AM; Ooi MH; de Bruyne J; Byrnes CA; Lee B; Nachiappan N; Saari N; Torzillo P; Smith-Vaughan H; Morris PS; Upham JW; Grimwood K
    BMJ Open; 2019 Apr; 9(4):e026411. PubMed ID: 31023759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
    Barratt S; Bielicki JA; Dunn D; Faust SN; Finn A; Harper L; Jackson P; Lyttle MD; Powell CV; Rogers L; Roland D; Stöhr W; Sturgeon K; Vitale E; Wan M; Gibb DM; Sharland M
    Health Technol Assess; 2021 Nov; 25(60):1-72. PubMed ID: 34738518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled Trial.
    Kok HC; McCallum GB; Yerkovich ST; Grimwood K; Fong SM; Nathan AM; Byrnes CA; Ware RS; Nachiappan N; Saari N; Morris PS; Yeo TW; Oguoma VM; Masters IB; de Bruyne JA; Eg KP; Lee B; Ooi MH; Upham JW; Torzillo PJ; Chang AB
    Pediatr Infect Dis J; 2024 Sep; 43(9):872-879. PubMed ID: 38830139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of a personalised
    Marchant JM; Chang AB; Schutz KL; Versteegh L; Cook A; Roberts J; Morris PS; Yerkovich ST; McCallum GB
    BMJ Open; 2021 Dec; 11(12):e049007. PubMed ID: 34937712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB
    Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol.
    Chang AB; Grimwood K; White AV; Maclennan C; Sloots TP; Sive A; McCallum GB; Mackay IM; Morris PS
    Trials; 2011 Apr; 12():94. PubMed ID: 21492416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial.
    McCallum GB; Fong SM; Grimwood K; Nathan AM; Byrnes CA; Ooi MH; Nachiappan N; Saari N; Morris PS; Yeo TW; Ware RS; Elogius BW; Oguoma VM; Yerkovich ST; de Bruyne J; Lawrence KA; Lee B; Upham JW; Torzillo PJ; Chang AB
    Pediatr Infect Dis J; 2022 Jul; 41(7):549-555. PubMed ID: 35476706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.
    Valery PC; Morris PS; Grimwood K; Torzillo PJ; Byrnes CA; Masters IB; Bauert PA; McCallum GB; Mobberly C; Chang AB
    BMC Pediatr; 2012 Aug; 12():122. PubMed ID: 22891748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial.
    Ruffles TJC; Goyal V; Marchant JM; Masters IB; Yerkovich S; Buntain H; Cook A; Schultz A; Upham JW; Champion A; Versteegh L; Chang AB
    Lancet Respir Med; 2021 Oct; 9(10):1121-1129. PubMed ID: 34048716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB; Grimwood K; Wilson AC; van Asperen PP; Byrnes CA; O'Grady KA; Sloots TP; Robertson CF; Torzillo PJ; McCallum GB; Masters IB; Buntain HM; Mackay IM; Ungerer J; Tuppin J; Morris PS
    Trials; 2013 Feb; 14():53. PubMed ID: 23421781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
    Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
    Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
    Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
    BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial.
    Chang AB; Yerkovich ST; Baines KJ; Burr L; Champion A; Chatfield MD; Eg KP; Goyal V; Marsh RL; McCallum GB; McElrea M; McPhail S; Morgan LC; Morris PS; Nathan AM; O'Farrell H; Sanchez MO; Parsons M; Schultz A; Torzillo PJ; West NP; Versteegh L; Marchant JM; Grimwood K
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38719503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.
    O'Grady KA; Grimwood K; Cripps A; Mulholland EK; Morris P; Torzillo PJ; Wood N; Smith-Vaughan H; Revell A; Wilson A; Van Asperen P; Richmond P; Thornton R; Rablin S; Chang AB
    Trials; 2013 Sep; 14():282. PubMed ID: 24010917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.